Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Primary endpoint of the study is to prove the superiority of an adjuvant therapy with
oxaliplatin/ capecitabine until the first occurrence of appearance of a tumour. Occurrences
in the meaning of this study are the appearance of a relapse of the tumour, of metastases, of
a second tumour or death of any reason.